A 23-year-old Aboriginal woman living in a remote community has a history of definite acute rheumatic fever at age 12 and moderate rheumatic mitral regurgitation. She is otherwise well. According to current Australian ARF/RHD guidelines, which secondary prophylaxis regimen is most appropriate?